12 Highlights from 2019 - China, Cancer Trials and Even Better Breath Biopsy

Published on 31 Dec 19, under PAN, Press mentions

With 2019 coming to a close, we take a look back over an exciting year for Owlstone Medical which has seen some major changes for our Breath Biopsy® platform. In case you missed anything, we've collected together our highlights from the last year for you to enjoy.

2019hl PAN
In January, we launched the PAN Cancer Trail in partnership with Addenbrooke's Hospital and supported by Cancer Research UK. The lauch was covered extensively in the press and has been written about in a number of articles and editorials by cancer researcher Balkees Abderrahman.

READ THE ANNOUNCEMENT SEE PRESS COVERAGE READ EDITORIAL

2019hl China
A deal with Renji Hospital in Shanghai became the first venture for Breath Biopsy into China with a project investigating biomarkers to detect lung cancer.

READ THE ANNOUNCEMENT

2019hl Asthma
With support from Asthma UK and Innovate UK, we announced a collaboration with the University of Manchester to identify biomarkers for asthma diagnostics.

READ THE ANNOUNCEMENT

A study by Schleich et al. published this year also revealed new potential breath biomarkers for differentiating asthma types.

READ OUR BLOG

2019hl PH
We announced an investigation of pulmonary hypertension in partnership with Actelion, part of the Janssen Group.

READ THE ANNOUNCEMENT

2019hl EVOC
The launch of EVOC® Probes represented a new direction for Breath Biopsy, unlocking the potential to take a targeted approach to breath analysis.

READ THE ANNOUNCEMENT

One of the key benefits of targeted biomarker studies is the ability to understand the biology behind the biomarkers. In our blog, Rianne Fijten, a researcher from Maastricht, considered the importance of understanding the links between biology and biomarkers.

READ THE BLOG

2019hl Products
In September we revealed the updated line of Breath Biopsy products, ReCIVA® Breath Sampler and CASPER™ Portable Air Supply.

READ THE ANNOUNCEMENT READ THE BLOG DISCOVER ReCIVA

On LinkedIn, we also spoke to Steph, one of the Engineers about her role in creating the new CASPER:

MEET STEPH

2019hl Awards
In 2019 we won the Business Weekly ScaleUP of the Year Award and the Cambridge Independent Science & Technology Life Science Company of the Year. EVOC Probes were also named as one of The Scientist's Top 10 Innovations of 2019.

SEE AWARDS TOP 10 INNOVATIONS 2019

2019hl Cleveland Clinic
We're supporting Cleveland Clinic to establish a Center for Early Detection with an initial project looking to identify the early signs of liver disease.

READ THE ANNOUNCEMENT

In our blog we looked at the links between breath biomarkers and liver diseases.

READ THE BLOG

2019hl 3TR
The 3TR consortium is the largest immunology project to be supported by the Innovative Medicine Initiative 2 (IMI2). The project covers seven conditions; systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease (including ulcerative colitis and Crohn’s disease), asthma and chronic obstructive pulmonary disease (COPD). Our work will initially contribute to efforts around asthma and COPD.

READ THE ANNOUNCEMENT

2019hl Thermo
An agreement with Thermo Scientific means we're integrating their Orbitrap GC-MS technology into the Breath Biopsy pipeline improving our ability to detect key disease biomarkers.

READ THE ANNOUNCEMENT

2019hl BBcon
In 2019 we hosted the second Breath Biopsy Conference the program was even larger with more talks and an expert discussion session. Take a look at our blogs to explore the key themes of the conference and what the delegates had to say. You can also find full talks and abstracts on the Breath Biopsy Community. Details of the next conference will be available soon, so register your interest now.

READ THE BLOG WHAT THE DELEGATES SAID VISIT THE COMMUNITY

REGISTER INTEREST IN BREATH BIOPSY CONFERENCE

2019hl Exposure
Breath Biopsy has other applications beyond searching for signs of disease. In 2019 we embarked on two projects relating to environmental exposure, looking at biomarkers for detecting exposure to certain substances. Working with the International Association of Heat and Frost Insulators and Allied Workers (IAHFIAW) we're investigating factors contributing to the development of mesothelioma, while the EU-funded EPHOR consortium is exploring the exposome with the goal of reducing the disease burden resulting from workplace exposures.

OUR WORK WITH IAHFIAW READ ABOUT EPHOR

To get all the latest news from Owlstone Medical as it happens, sign up to our Newsletter, or look out for us at these upcoming events.

Get updates about the next Breath Biopsy Conference

Express Interest